person · Reporting owner
Fairmount Healthcare Co-Invest II L.P.
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Apogee Therapeutics, Inc.APGE · Entity 1939 | Director | January 29, 2024 | January 31, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Apogee Therapeutics, Inc.
Report date January 29, 2024 · Filed January 31, 2024
Jointly reported with Fairmount Funds Management LLC, Fairmount Healthcare Fund L.P., Fairmount Healthcare Fund II L.P., Kiselak Tomas, Harwin Peter Evan
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Fairmount Healthcare Co-Invest II LP | 0 |
Reported balance
After 2024-01-29 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-01-29 · Other · Disposed 892,529 · Balance 0 F1: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023. F2: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund L.P. ("Fund I"), Fairmount Healthcare Fund II L.P. ("Fund II") and Co-Invest. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. |
| Common StockSEC Table I · non-derivative | IndirectBy Tomas Kiselak | 51,166 |
Reported balance
After 2024-01-29 transaction · row 2
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 2 · 2024-01-29 · Other · Acquired 51,166 · Balance 51,166 F1: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023. |
| Common StockSEC Table I · non-derivative | IndirectBy Peter Harwin | 51,166 |
Reported balance
After 2024-01-29 transaction · row 3
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 3 · 2024-01-29 · Other · Acquired 51,166 · Balance 51,166 F1: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023.
F2: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund L.P. ("Fund I"), Fairmount Healthcare Fund II L.P. ("Fund II") and Co-Invest. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 29, 2024 Filed Jan 31, 2024 16:31 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | OtherCommon Stock | 51,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008835 · tm244753-2_4seq1.xml · nonDerivative · entry 3 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By Peter Harwin Disclosed balance after: 51,166 F1 · kind: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 16:31 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | OtherCommon Stock | 51,166 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008835 · tm244753-2_4seq1.xml · nonDerivative · entry 2 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By Tomas Kiselak Disclosed balance after: 51,166 F1 · kind: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023. Read SEC document |
| January 29, 2024 Filed Jan 31, 2024 16:31 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | OtherCommon Stock | 892,529 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-008835 · tm244753-2_4seq1.xml · nonDerivative · entry 1 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Plan reported Ownership: Indirect · By Fairmount Healthcare Co-Invest II LP Disclosed balance after: 0 F1 · kind: Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Fairmount Healthcare Co-Invest II LP ("Co-Invest") to its limited partners pursuant to a Rule 10b5-1 trading plan adopted by Co-Invest on September 29, 2023. F2 · ownership.nature: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund L.P. ("Fund I"), Fairmount Healthcare Fund II L.P. ("Fund II") and Co-Invest. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:00 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | GrantStock Option (Right to Buy) · Derivative | 47,758 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081729 · tm2321456-6_4seq1.xml · derivative · entry 5 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,758 Underlying: Common Stock · 47,758 shares Expires 2033-07-13 F2 · derivative.exercise_date: This option represents the right to purchase 47,758 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date. F4 · ownership.direct: Under Mr. Kiselak's arrangement with Fairmount, Mr. Kiselak holds the option for one or more Fairmount Funds. Mr. Kiselak is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Kiselak therefore disclaims beneficial ownership of the option and underlying common stock. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:00 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | GrantStock Option (Right to Buy) · Derivative | 47,758 | $0.00 Strike: $17.00 | $0.00 |
DisclosureSEC source: 0001104659-23-081729 · tm2321456-6_4seq1.xml · derivative · entry 4 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,758 Underlying: Common Stock · 47,758 shares Expires 2033-07-13 F2 · derivative.exercise_date: This option represents the right to purchase 47,758 shares of the Issuer's common stock, and will vest in three approximately equal annual installments beginning on the first anniversary of the grant date. F3 · ownership.direct: Under Mr. Harwin's arrangement with Fairmount, Mr. Harwin holds the option for one or more investment vehicles managed by Fairmount (each, a "Fairmount Fund"). Mr. Harwin is obligated to turn over to Fairmount any net cash or stock received from the option for the benefit of such Fairmount Fund. Mr. Harwin therefore disclaims beneficial ownership of the option and underlying common stock. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:00 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | PurchaseCommon Stock | 892,529 | $17.00 | $15,172,993.00 |
DisclosureSEC source: 0001104659-23-081729 · tm2321456-6_4seq1.xml · nonDerivative · entry 3 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Fairmount Healthcare Co-Invest II LP Disclosed balance after: 892,529 F1 · ownership.nature: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:00 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | PurchaseCommon Stock | 1,992,734 | $17.00 | $33,876,478.00 |
DisclosureSEC source: 0001104659-23-081729 · tm2321456-6_4seq1.xml · nonDerivative · entry 2 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Fairmount Healthcare Fund II LP Disclosed balance after: 1,992,734 F1 · ownership.nature: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
| July 13, 2023 Filed Jul 17, 2023 20:00 UTC | Apogee Therapeutics, Inc. APGE · Entity 1939 | PurchaseCommon Stock | 55,913 | $17.00 | $950,521.00 |
DisclosureSEC source: 0001104659-23-081729 · tm2321456-6_4seq1.xml · nonDerivative · entry 1 Fairmount Funds Management LLC · CIK 0001802528 · Director Fairmount Healthcare Fund L.P. · CIK 0001686157 · Director Fairmount Healthcare Fund II L.P. · CIK 0001769651 · Director Fairmount Healthcare Co-Invest II L.P. · CIK 0001982189 · Director Kiselak Tomas · CIK 0001830177 · Director Harwin Peter Evan · CIK 0001663607 · Director Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Fairmount Healthcare Fund LP Disclosed balance after: 55,913 F1 · ownership.nature: Fairmount Funds Management LLC ("Fairmount") is the investment manager for Fairmount Healthcare Fund LP, Fairmount Healthcare Fund II LP and Fairmount Healthcare Co-Invest II LP. The general partner of Fairmount is Fairmount Funds Management GP LLC ("Fairmount GP"), of which Peter Harwin and Tomas Kiselak are the managing members. Fairmount, Fairmount GP, Mr. Harwin, and Mr. Kiselak disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.